308 related articles for article (PubMed ID: 29463745)
1. Rocaglates as dual-targeting agents for experimental cerebral malaria.
Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
[TBL] [Abstract][Full Text] [Related]
2. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
[TBL] [Abstract][Full Text] [Related]
3. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
4. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
[TBL] [Abstract][Full Text] [Related]
5. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
[TBL] [Abstract][Full Text] [Related]
6. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
[TBL] [Abstract][Full Text] [Related]
7. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
8. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties.
Camara A; Haddad M; Reybier K; Traoré MS; Baldé MA; Royo J; Baldé AO; Batigne P; Haidara M; Baldé ES; Coste A; Baldé AM; Aubouy A
Malar J; 2019 Dec; 18(1):431. PubMed ID: 31852507
[TBL] [Abstract][Full Text] [Related]
9. Improved efficacy of doxycycline in liposomes against Plasmodium falciparum in culture and Plasmodium berghei infection in mice.
Rajendran V; Singh C; Ghosh PC
Can J Physiol Pharmacol; 2018 Nov; 96(11):1145-1152. PubMed ID: 30075085
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen activity against Plasmodium in vitro and in mice.
Weinstock A; Gallego-Delgado J; Gomes C; Sherman J; Nikain C; Gonzalez S; Fisher E; Rodriguez A
Malar J; 2019 Nov; 18(1):378. PubMed ID: 31775753
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.
Torre S; Langlais D; Gros P
Mamm Genome; 2018 Aug; 29(7-8):488-506. PubMed ID: 29922917
[TBL] [Abstract][Full Text] [Related]
12. The machinery underlying malaria parasite virulence is conserved between rodent and human malaria parasites.
De Niz M; Ullrich AK; Heiber A; Blancke Soares A; Pick C; Lyck R; Keller D; Kaiser G; Prado M; Flemming S; Del Portillo H; Janse CJ; Heussler V; Spielmann T
Nat Commun; 2016 May; 7():11659. PubMed ID: 27225796
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial and antiplasmodial activity of husk extract and fractions of Zea mays.
Okokon JE; Antia BS; Mohanakrishnan D; Sahal D
Pharm Biol; 2017 Dec; 55(1):1394-1400. PubMed ID: 28320254
[TBL] [Abstract][Full Text] [Related]
14. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
Konziase B
J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
[TBL] [Abstract][Full Text] [Related]
15. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and genes regulation of cerebral malaria upon Zizyphus spina-christi treatment in a murine model.
Mubaraki MA; Hafiz TA; Al-Quraishy S; Dkhil MA
Microb Pathog; 2017 Jun; 107():69-74. PubMed ID: 28336326
[TBL] [Abstract][Full Text] [Related]
17. Ethanolic extract of the fungus Trichoderma stromaticum decreases inflammation and ameliorates experimental cerebral malaria in C57BL/6 mice.
Cariaco Y; Lima WR; Sousa R; Nascimento LAC; Briceño MP; Fotoran WL; Wunderlich G; Dos Santos JL; Silva NM
Sci Rep; 2018 Jan; 8(1):1547. PubMed ID: 29367729
[TBL] [Abstract][Full Text] [Related]
18. Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors.
Mejia P; Diez-Silva M; Kamena F; Lu F; Fernandes SM; Seeberger PH; Davis AE; Mitchell JR
J Infect Dis; 2016 Jan; 213(1):80-9. PubMed ID: 26347576
[TBL] [Abstract][Full Text] [Related]
19. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
